# A Study to Evaluate Solrikitug in Participants With COPD (ZION)

> **NCT06496620** · PHASE2 · RECRUITING · sponsor: **Uniquity One (UNI)** · enrollment: 171 (estimated)

## Conditions studied

- COPD

## Interventions

- **BIOLOGICAL:** Biological: Solrikitug low dose
- **BIOLOGICAL:** Biological: Solrikitug high dose
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06496620
- **Lead sponsor:** Uniquity One (UNI)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-14
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-10-31
- **Target enrollment:** 171 (ESTIMATED)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06496620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06496620, "A Study to Evaluate Solrikitug in Participants With COPD (ZION)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06496620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*